Marcus Reif

Comparison of Orally Administered Cannabis Extract and Delta-9-Tetrahydrocannabinol in Treating Patients With Cancer-Related Anorexia-Cachexia Syndrome: A Multicenter, Phase III, Randomized, Double-Blind, Placebo-Controlled Clinical Trial From the Cannabis-In-Cachexia-Study-Group

Florian Strasser, Diana Lüftner, Kurt Possinger et al. · Journal of Clinical Oncology · 2006 · 402 citations · Full text

Efficacy, safety and tolerability of an orally administered cannabis extract in the treatment of spasticity in patients with multiple sclerosis: a randomized, double-blind, placebo-controlled, crossover study

Claude Vaney, Monika Heinzel‐Gutenbrunner, P Jobin et al. · Multiple Sclerosis Journal · 2004 · 256 citations

Safety, tolerability, and efficacy of orally administered cannabinoids in MS

Joep Killestein, E.L.J. Hoogervorst, Marcus Reif et al. · Neurology · 2002 · 203 citations

Viscum album [L.] extract therapy in patients with locally advanced or metastatic pancreatic cancer: A randomised clinical trial on overall survival

Wilfried Tröger, Danijel Galun, Marcus Reif et al. · European Journal of Cancer · 2013 · 192 citations

Lack of Analgesia by Oral Standardized Cannabis Extract on Acute Inflammatory Pain and Hyperalgesia in Volunteers

Nathalie Frickey, Rainer Kaufmann, Marcus Reif et al. · Anesthesiology · 2008 · 126 citations · Full text